World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
12260
World Ranking
2963
National Ranking
1393

James B. Dale publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where James B. Dale sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 180 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

James B. Dale D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where James B. Dale sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

James B. Dale is affiliated with the University of Tennessee Health Science Center in the United States. Their research primarily focuses on medicine, with significant contributions to public health, environmental and occupational health, infectious diseases, epidemiology, clinical biochemistry, and molecular biology.

The scientist's main research topics include streptococcal infections and treatments, antimicrobial resistance in Staphylococcus, neonatal and maternal infections, otolaryngology and infectious diseases, infective endocarditis diagnosis and management, bacterial identification and susceptibility testing, and immune response and inflammation.

Recent publications by James B. Dale cover a range of topics within infectious diseases and public health:

  • Update on group A streptococcal vaccine development (2020), published in Current Opinion in Infectious Diseases
  • A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study (2021), published in The Lancet Microbe
  • The American Heart Association's Call to Action for Reducing the Global Burden of Rheumatic Heart Disease: A Policy Statement From the American Heart Association (2020), published in Circulation
  • Prevalence of group A β-hemolytic streptococcal throat carriage and prospective pilot surveillance of streptococcal sore throat in Ugandan school children (2020), published in International Journal of Infectious Diseases
  • Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal emm Clusters in Africa To Inform Vaccine Development (2020), published in mSphere

Frequently collaborating with James B. Dale are Mark E. Engel, Babu Muhamed, Kélin Engel, Andrea Beaton, and Michelle P. Aranha.

Their research has been published predominantly in the following venues:

  • Vaccine
  • Circulation
  • mSphere
  • Current Opinion in Infectious Diseases
  • The Lancet Microbe

Best Publications

  • Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection

    Felipe A. Pinho-Ribeiro;Buket Baddal;Rianne Haarsma;Maghnus O’Seaghdha

  • Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

    Shelly A. McNeil;Scott A. Halperin;Joanne M. Langley;Bruce Smith

  • New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.

    James B. Dale;Thomas A. Penfound;Thomas A. Penfound;Edna Y. Chiang;Edna Y. Chiang;William J. Walton

  • A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development

    Martina L Sanderson-Smith;David M P De Oliveira;Julien Guglielmini;David J McMillan

  • Immunogenicity of a 26-valent group A streptococcal vaccine

    Mary C. Hu;Michael A. Walls;Steven D. Stroop;Mark A. Reddish

  • Epitopes of streptococcal M proteins shared with cardiac myosin.

    James B. Dale;Edwin H. Beachey

  • Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.

    M S Bronze;J B Dale

  • Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci

    J B Dale;R G Washburn;M B Marques;M R Wessels

  • Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci.

    H. S. Courtney;Yi Li;J. B. Dale;D. L. Hasty

  • Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein

    Edwin H. Beachey;Jerome M. Seyer;James B. Dale;W. Andrew Simpson

  • Prevalence of Rheumatic Heart Disease in Children and Young Adults in Nicaragua

    John A. Paar;Nubia M. Berrios;John D. Rose;Mercedes Cáceres

  • Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci.

    Harry S Courtney;David L Hasty;James B Dale

  • Streptococcal C5a peptidase is a highly specific endopeptidase.

    P P Cleary;U Prahbu;J B Dale;D E Wexler

  • Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein.

    M W Cunningham;J M McCormack;P G Fenderson;M K Ho

  • Multiple, heart-cross-reactive epitopes of streptococcal M proteins.

    James B. Dale;Edwin H. Beachey

  • Safety and immunogenicity of a recombinant multivalent Group A streptococcal Vaccine in healthy adults: Phase 1 trial

    Karen L. Kotloff;Mary Corretti;Mary Corretti;Kathleen Palmer;James D. Campbell

  • Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

    James B Dale

  • SERUM OPACITY FACTOR IS A MAJOR FIBRONECTIN-BINDING PROTEIN AND A VIRULENCE DETERMINANT OF M TYPE 2 STREPTOCOCCUS PYOGENES

    Harry S. Courtney;David L. Hasty;David L. Hasty;Yi Li;Herbert C. Chiang

  • Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

    Stanford T. Shulman;Robert R. Tanz;William Kabat;Kathleen Kabat

  • Temporal Changes in Streptococcal M Protein Types and the Near-Disappearance of Acute Rheumatic Fever in the United States

    Stanford T. Shulman;Gene Stollerman;Bernard Beall;James B. Dale

  • Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart.

    James Dale;Edwin H. Beachey

Frequent Co-Authors

David L. Hasty
David L. Hasty University of Tennessee Health Science Center
Edwin H. Beachey
Edwin H. Beachey University of Tennessee Health Science Center
Stanford T. Shulman
Stanford T. Shulman Northwestern University
Bernard Beall
Bernard Beall Centers for Disease Control and Prevention
Jonathan R. Carapetis
Jonathan R. Carapetis Telethon Kids Institute
Jerome M. Seyer
Jerome M. Seyer University of Tennessee Health Science Center
P. Patrick Cleary
P. Patrick Cleary University of Minnesota
Michael F. Good
Michael F. Good Griffith University
Shelly A. McNeil
Shelly A. McNeil Dalhousie University
Itzhak Ofek
Itzhak Ofek Tel Aviv University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals consider bridging their background with nursing, especially through programs designed to accelerate career growth in clinical settings.

Nurses aiming to specialize further might explore acute care nurse practitioner programs. These programs prepare nurses to handle complex patient care, making them valuable in immunology-focused clinical environments, such as infectious disease units or immunotherapy clinics.

Alternatively, students new to healthcare can begin with best online rn programs for non nurses, designed to provide foundational training remotely. These programs can be a gateway for those shifting careers or expanding their knowledge in the biomedical sciences.

Accelerated pathways, like accelerated fnp programs and easiest absn program to get into, offer fast-tracked options for becoming a nurse practitioner or registered nurse. These are ideal for students who want to quickly enter the workforce while gaining specialized skills applicable to immunological healthcare roles.

Best Scientists Citing James B. Dale

Trending Scientists

Recently Published Articles